Albert Kildani | VP, IR & Corporate Communications |
Helen Torley | President, CEO & Director |
Laurie Stelzer | SVP & CFO |
Alison Armour | SVP, R&D |
Charles Duncan | Cantor Fitzgerald |
Jim Birchenough | Wells Fargo |
Jason Butler | JMP Securities |
Joel Beatty | Citigroup |
Good afternoon, everyone. I would now like to turn the conference over to Al Kildani, Vice President of Investor Relations and Corporate Communications for Halozyme Therapeutics. Mr. Kildani, please begin.
Good afternoon, and welcome to our Second Quarter 2019 Financial Results Conference Call.